Page 1 | Search Results | Diabetes | American Diabetes Association

1-16 of 16

Sort by

Sort Order Select

Meeting Abstracts

2020-LB: Immunometabolomics Reveals Little Autoimmunity in Type 1 Diabetes (T1D)—Cross-Sectional Pathway Analysis across Multiple Autoimmune Diseases

FERNANDA MONEDEIRO, ELMAR ZÜGNER, BARBARA PRIETL, MONIKA OBERHUBER, MARTIN STRADNER, MICHAEL KHALIL, CHRISTOPH MAGNES, THOMAS PIEBER

Diabetes 2024;73(Supplement_1):2020-LB

https://doi.org/10.2337/db24-2020-LB

Published: 14 June 2024

View article titled, 2020-LB: Immunometabolomics Reveals Little Autoimmunity in Type 1 Diabetes (T1D)—Cross-Sectional Pathway Analysis across Multiple Autoimmune Diseases

Meeting Abstracts

129-OR: Effect of Tirzepatide on the Counterregulatory Response to Hypoglycemia during a Hypoglycemic Clamp in People with Type 2 Diabetes

THOMAS PIEBER, EVA SVEHLIKOVA, SHWETA URVA, AXEL HAUPT, CHUNMEI ZHOU, TAMER COSKUN, ZVONKO MILICEVIC, EDWARD J. PRATT

Diabetes 2023;72(Supplement_1):129-OR

https://doi.org/10.2337/db23-129-OR

Published: 20 June 2023

View article titled, 129-OR: Effect of Tirzepatide on the Counterregulatory Response to Hypoglycemia during a Hypoglycemic Clamp in People with Type 2 Diabetes

Meeting Abstracts

805-P: Double-Blind Crossover Study of Ultra-Rapid AT247 Compared with NovoLog and Fiasp during Continuous Subcutaneous Infusion (CSII) Assessed by a Hyperinsulinemic Euglycemic Clamp

MARCUS HOMPESCH, FIONA J. LAWRENCE, JAN JEZEK, DAVID J. GERRING, THOMAS PIEBER

Diabetes 2023;72(Supplement_1):805-P

https://doi.org/10.2337/db23-805-P

Published: 20 June 2023

View article titled, 805-P: Double-Blind Crossover Study of Ultra-Rapid AT247 Compared with NovoLog and Fiasp during Continuous Subcutaneous Infusion (CSII) Assessed by a Hyperinsulinemic Euglycemic Clamp

Meeting Abstracts

202-OR: Automated Cluster Analysis by Machine Learning Reveals Important Dissimilarities in the Immune Phenotype of T1D, MS, and SLE

BARBARA PRIETL, JOSÉ ANTONIO VERA-RAMOS, VERENA PFEIFER, MICHAEL KHALIL, LAURIN HERBSTHOFER, HARALD SOURIJ, THOMAS PIEBER

Diabetes 2023;72(Supplement_1):202-OR

https://doi.org/10.2337/db23-202-OR

Published: 20 June 2023

View article titled, 202-OR: Automated Cluster Analysis by Machine Learning Reveals Important Dissimilarities in the Immune Phenotype of T1D, MS, and SLE

Journal Articles

Tracking Ca²⁺ Dynamics in NOD Mouse Islets During Spontaneous Diabetes Development

Sandra Postić, Johannes Pfabe, Srdjan Sarikas, Barbara Ehall, Thomas Pieber, Dean Korošak, Marjan Slak Rupnik, Ya-Chi Huang

Diabetes 2023;72(9):1251–1261

https://doi.org/10.2337/db22-0952

Published: 31 May 2023

View article titled, Tracking Ca<sup>2+</sup> Dynamics in NOD Mouse Islets During Spontaneous Diabetes Development

Meeting Abstracts

1287-P: Deep Immune Phenotyping of Type 1 Diabetes by Machine Learning

JOSÉ ANTONIO VERA-RAMOS, BARBARA PRIETL, LAURIN HERBSTHOFER, VERENA PFEIFER, PABLO LÓPEZ-GARCÍA, MARTIN STRADNER, THOMAS PIEBER

Diabetes 2022;71(Supplement_1):1287-P

https://doi.org/10.2337/db22-1287-P

Published: 01 June 2022

View article titled, 1287-P: Deep Immune Phenotyping of Type 1 Diabetes by Machine Learning

Meeting Abstracts

216-OR: Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D

EVA SVEHLIKOVA, KRISTINE NISS ARFELT, ROMAN CAILLETEAU, SIGRID DELLER, KAREN MARGRETE THOMSEN, MARLIES HART, INES MURSIC, THOMAS PIEBER, HANNE HAAHR

Diabetes 2022;71(Supplement_1):216-OR

https://doi.org/10.2337/db22-216-OR

Published: 01 June 2022

View article titled, 216-OR: Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D

Meeting Abstracts

700-P: Glucotab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using Insulin Degludec

JULIA K. MADER, PETRA M. BAUMANN, FELIX ABERER, DANIEL A. HOCHFELLNER, AMRA SIMIC, LIRIE BYTYQI, TINA POETTLER, BERNHARD HOELL, ASTRID FAHRLEITNER-PAMMER, THOMAS PIEBER, PETER BECK

Diabetes 2021;70(Supplement_1):700-P

https://doi.org/10.2337/db21-700-P

Published: 01 June 2021

View article titled, 700-P: Glucotab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using Insulin Degludec

Meeting Abstracts

624-P: Sustained Effect in Diabetes Management Using a Digital Workflow and Decision Support System in Home Health Care

JULIA KOPANZ, LARA K. SCHOLLE, KATHARINA M. LICHTENEGGER, GISELA AMBROSCH, ANGELA LIBISELLER, FELIX ABERER, MARLENE PANDIS, KLAUS DONSA, THOMAS TRUSKALLER, THOMAS PIEBER, JULIA K. MADER

Diabetes 2021;70(Supplement_1):624-P

https://doi.org/10.2337/db21-624-P

Published: 01 June 2021

View article titled, 624-P: Sustained Effect in Diabetes Management Using a Digital Workflow and Decision Support System in Home Health Care

Meeting Abstracts

344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia

SIMON R. HELLER, TADEJ BATTELINO, TIMOTHY S. BAILEY, RAMIN TEHRANCHI, LESLIE J. KLAFF, THOMAS PIEBER, ULRIKE HÖVELMANN, LEONA PLUM-MOERSCHEL, ANITA E. MELGAARD, RONNIE ARONSON, LINDA DIMEGLIO, THOMAS DANNE

Diabetes 2021;70(Supplement_1):344-P

https://doi.org/10.2337/db21-344-P

Published: 01 June 2021

View article titled, 344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia

Meeting Abstracts

345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups

TADEJ BATTELINO, TIMOTHY S. BAILEY, RAMIN TEHRANCHI, LESLIE J. KLAFF, THOMAS PIEBER, ULRIKE HÖVELMANN, LEONA PLUM-MOERSCHEL, ANITA E. MELGAARD, RONNIE ARONSON, LINDA DIMEGLIO, THOMAS DANNE

Diabetes 2021;70(Supplement_1):345-P

https://doi.org/10.2337/db21-345-P

Published: 01 June 2021

View article titled, 345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups

Meeting Abstracts

346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon

TADEJ BATTELINO, TIMOTHY S. BAILEY, RAMIN TEHRANCHI, LESLIE J. KLAFF, THOMAS PIEBER, ULRIKE HÖVELMANN, LEONA PLUM-MOERSCHEL, ANITA E. MELGAARD, RONNIE ARONSON, LINDA DIMEGLIO, THOMAS DANNE, ANNE L. PETERS

Diabetes 2021;70(Supplement_1):346-P

https://doi.org/10.2337/db21-346-P

Published: 01 June 2021

View article titled, 346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon

Meeting Abstracts

25-OR: Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i)

INES MURSIC, EVA SVEHLIKOVA, WERNER REGITTNIG, THOMAS AUGUSTIN, CHRISTOPH MAGNES, ANITA EBERL, TIM HEISE, OLIVER KLEIN, MICHAEL WOLF, MARTINA URSCHITZ, MARTINA BRUNNER, HARALD SOURIJ, THOMAS PIEBER

Diabetes 2020;69(Supplement_1):25-OR

https://doi.org/10.2337/db20-25-OR

Published: 01 June 2020

View article titled, 25-OR: Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i)

Meeting Abstracts

278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

MATTHIAS G. VON HERRATH, STEPHEN C. BAIN, BRUCE W. BODE, JESPER OLE CLAUSEN, KEN COPPIETERS, LEYLYA GAYSINA, JANUSZ GUMPRECHT, TROELS K. HANSEN, CHANTAL MATHIEU, CRISTOBAL MORALES PORTILLO, OFRI MOSENZON, STINE SEGEL, GEORGE M. TSOUKAS, THOMAS PIEBER

Diabetes 2020;69(Supplement_1):278-OR

https://doi.org/10.2337/db20-278-OR

Published: 01 June 2020

View article titled, 278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

Meeting Abstracts

1666-P: Increased Levels of Autophagy in a Rodent Model of Type 1 Diabetes

CEREN KARACAY, PETRA KOTZBECK, BARBARA PRIETL, CLEMENS HARER, THOMAS PIEBER

Diabetes 2020;69(Supplement_1):1666-P

https://doi.org/10.2337/db20-1666-P

Published: 01 June 2020

View article titled, 1666-P: Increased Levels of Autophagy in a Rodent Model of Type 1 Diabetes

Meeting Abstracts

2085-P: Effects of Intermittent Caloric Restriction on Body Composition and Glucose Tolerance after Fasting and Refeeding

CLEMENS HARER, JELENA KRSTIC, PETRA KOTZBECK, CEREN KARACAY, ANDREAS PROKESCH, THOMAS PIEBER

Diabetes 2020;69(Supplement_1):2085-P

https://doi.org/10.2337/db20-2085-P

Published: 01 June 2020

View article titled, 2085-P: Effects of Intermittent Caloric Restriction on Body Composition and Glucose Tolerance after Fasting and Refeeding

NARROW

2020-LB: Immunometabolomics Reveals Little Autoimmunity in Type 1 Diabetes (T1D)—Cross-Sectional Pathway Analysis across Multiple Autoimmune Diseases

129-OR: Effect of Tirzepatide on the Counterregulatory Response to Hypoglycemia during a Hypoglycemic Clamp in People with Type 2 Diabetes

805-P: Double-Blind Crossover Study of Ultra-Rapid AT247 Compared with NovoLog and Fiasp during Continuous Subcutaneous Infusion (CSII) Assessed by a Hyperinsulinemic Euglycemic Clamp

202-OR: Automated Cluster Analysis by Machine Learning Reveals Important Dissimilarities in the Immune Phenotype of T1D, MS, and SLE

Tracking Ca²⁺ Dynamics in NOD Mouse Islets During Spontaneous Diabetes Development

1287-P: Deep Immune Phenotyping of Type 1 Diabetes by Machine Learning

216-OR: Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D

700-P: Glucotab-Based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using Insulin Degludec

624-P: Sustained Effect in Diabetes Management Using a Digital Workflow and Decision Support System in Home Health Care

344-P: Integrated Safety Analysis of Dasiglucagon for Treatment of Severe Hypoglycemia

345-P: The Next Generation Glucagon Analog Dasiglucagon Consistently Achieves Rapid Recovery from Hypoglycemia across Subgroups

346-P: Predicting True Time to Recovery from Insulin-Induced Hypoglycemia with Dasiglucagon

25-OR: Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i)

278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes

1666-P: Increased Levels of Autophagy in a Rodent Model of Type 1 Diabetes

2085-P: Effects of Intermittent Caloric Restriction on Body Composition and Glucose Tolerance after Fasting and Refeeding

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

Email alerts

Journals

Books

Clinical Compendia

News

Other

About

Resources

This Feature Is Available To Subscribers Only